• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钙卫蛋白不稳定可能导致 IBD 患儿治疗不足。

Calprotectin instability may lead to undertreatment in children with IBD.

机构信息

Department of Pediatric Gastroenterology, Hepatology and Nutrition, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Department of Laboratory Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

出版信息

Arch Dis Child. 2020 Oct;105(10):996-998. doi: 10.1136/archdischild-2018-316584. Epub 2019 Jan 17.

DOI:10.1136/archdischild-2018-316584
PMID:30655264
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7513246/
Abstract

BACKGROUND

Treatment decisions in children with inflammatory bowel disease (IBD) are increasingly based on longitudinal tracking of faecal calprotectin concentrations, but there is little known about the stability of this protein in stool.

METHODS

We stored aliquots of homogenised stool at room temperature and at 4°C, and measured the calprotectin concentration for 6 consecutive days with three different assays. In addition, we assessed calprotectin stability in assay-specific extraction buffers kept at room temperature.

RESULTS

After 6 days of storage at room temperature, mean percentage change from baseline calprotectin concentrations in stool and extraction buffer was 35% and 46%, respectively. The stability of calprotectin was significantly better preserved in samples stored at 4°C (p=0.0066 and 0.0011, respectively).

CONCLUSIONS

Calprotectin is not stable at room temperature. Children with IBD and their caretakers may be falsely reassured by low calprotectin values. The best advisable standard for preanalytical calprotectin handling is refrigeration of the stool sample until delivery at the hospital laboratory.

摘要

背景

儿童炎症性肠病(IBD)的治疗决策越来越基于粪便钙卫蛋白浓度的纵向跟踪,但对该蛋白在粪便中的稳定性知之甚少。

方法

我们将匀浆粪便的等分试样分别在室温下和 4°C 下储存,并使用三种不同的检测方法连续 6 天测量钙卫蛋白浓度。此外,我们还评估了在室温下保存的特定检测提取缓冲液中钙卫蛋白的稳定性。

结果

在室温下储存 6 天后,粪便和提取缓冲液中基线钙卫蛋白浓度的平均百分比变化分别为 35%和 46%。与室温相比,钙卫蛋白在 4°C 下的稳定性显著更好(p=0.0066 和 0.0011,分别)。

结论

钙卫蛋白在室温下不稳定。IBD 患儿及其照顾者可能会被低钙卫蛋白值错误地安抚。在分析前处理钙卫蛋白时,最佳的标准建议是将粪便样本冷藏,直到送到医院实验室。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7efc/7513246/c6a514ec8118/archdischild-2018-316584f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7efc/7513246/ffb8ab8e072f/archdischild-2018-316584f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7efc/7513246/c6a514ec8118/archdischild-2018-316584f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7efc/7513246/ffb8ab8e072f/archdischild-2018-316584f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7efc/7513246/c6a514ec8118/archdischild-2018-316584f02.jpg

相似文献

1
Calprotectin instability may lead to undertreatment in children with IBD.钙卫蛋白不稳定可能导致 IBD 患儿治疗不足。
Arch Dis Child. 2020 Oct;105(10):996-998. doi: 10.1136/archdischild-2018-316584. Epub 2019 Jan 17.
2
Impact of Preanalytical Factors on Calprotectin Concentration in Stool: A Multiassay Comparison.分析前因素对粪便钙卫蛋白浓度的影响:多方法比较。
J Appl Lab Med. 2022 Oct 29;7(6):1401-1411. doi: 10.1093/jalm/jfac057.
3
Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children.粪便S100A12和粪便钙卫蛋白作为儿童炎症性肠病的非侵入性标志物。
Inflamm Bowel Dis. 2008 Mar;14(3):359-66. doi: 10.1002/ibd.20336.
4
The prognostic significance of faecal calprotectin in patients with inactive inflammatory bowel disease.粪便钙卫蛋白在非活动性炎症性肠病患者中的预后意义。
Aliment Pharmacol Ther. 2016 Sep;44(5):495-504. doi: 10.1111/apt.13731. Epub 2016 Jul 12.
5
Variability of Faecal Calprotectin in Inflammatory Bowel Disease Patients: An Observational Case-control Study.炎症性肠病患者粪便钙卫蛋白的变异性:一项观察性病例对照研究。
J Crohns Colitis. 2019 Oct 28;13(11):1372-1379. doi: 10.1093/ecco-jcc/jjz069.
6
The intra-individual variability of faecal calprotectin: a prospective study in patients with active ulcerative colitis.粪便钙卫蛋白的个体内变异性:活动性溃疡性结肠炎患者的前瞻性研究。
J Crohns Colitis. 2015 Jan;9(1):26-32. doi: 10.1016/j.crohns.2014.06.002.
7
Primary care faecal calprotectin testing in children with suspected inflammatory bowel disease: a diagnostic accuracy study.疑似炎症性肠病儿童的初级保健粪便钙卫蛋白检测:一项诊断准确性研究。
Arch Dis Child. 2020 Oct;105(10):957-963. doi: 10.1136/archdischild-2019-317823. Epub 2020 May 18.
8
Faecal calprotectin determination: impact of preanalytical sample treatment and stool consistency on within- and between-method variability.粪便钙卫蛋白测定:分析前样本处理和粪便稠度对方法内和方法间变异性的影响。
Biochem Med (Zagreb). 2019 Feb 15;29(1):010707. doi: 10.11613/BM.2019.010707.
9
Fecal calprotectin as a measure of disease activity in childhood inflammatory bowel disease.粪便钙卫蛋白作为儿童炎症性肠病疾病活动度的一项指标。
J Pediatr Gastroenterol Nutr. 2001 Feb;32(2):171-7. doi: 10.1097/00005176-200102000-00015.
10
Determination of faecal inflammatory marker concentration as a noninvasive method of evaluation of pathological activity in children with inflammatory bowel diseases.测定粪便炎症标志物浓度作为评估炎症性肠病患儿病理活动的一种非侵入性方法。
Adv Med Sci. 2015 Sep;60(2):246-52. doi: 10.1016/j.advms.2015.04.003. Epub 2015 Apr 29.

引用本文的文献

1
Probiotic acoustic biosensors for noninvasive imaging of gut inflammation.用于肠道炎症无创成像的益生菌声学生物传感器。
Nat Commun. 2025 Aug 25;16(1):7931. doi: 10.1038/s41467-025-62569-1.
2
Establishing reference values for age-related fecal calprotectin in healthy children aged 0-4 years: a systematic review and meta-analysis.建立0-4岁健康儿童年龄相关粪便钙卫蛋白的参考值:一项系统评价和荟萃分析。
PeerJ. 2025 Jun 12;13:e19572. doi: 10.7717/peerj.19572. eCollection 2025.
3
Diagnostic Procedures for Inflammatory Bowel Disease: Laboratory, Endoscopy, Pathology, Imaging, and Beyond.

本文引用的文献

1
Fecal Calprotectin: A Comparison of Two Commercial Enzymoimmunoassays and Study of Fecal Extract Stability at Room Temperature.粪便钙卫蛋白:两种商业酶免疫测定法的比较及粪便提取物在室温下的稳定性研究
J Clin Med Res. 2018 May;10(5):396-404. doi: 10.14740/jocmr3275e. Epub 2018 Mar 16.
2
Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial.紧密控制管理对克罗恩病(CALM)的影响:一项多中心、随机、对照的 3 期临床试验。
Lancet. 2017 Dec 23;390(10114):2779-2789. doi: 10.1016/S0140-6736(17)32641-7. Epub 2017 Oct 31.
3
Agreement Between Home-Based Measurement of Stool Calprotectin and ELISA Results for Monitoring Inflammatory Bowel Disease Activity.
炎症性肠病的诊断程序:实验室检查、内镜检查、病理学检查、影像学检查及其他
Diagnostics (Basel). 2024 Jun 28;14(13):1384. doi: 10.3390/diagnostics14131384.
4
Fecal calprotectin in pediatric gastrointestinal diseases: Pros and cons.粪便钙卫蛋白在儿童胃肠道疾病中的利弊
World J Clin Pediatr. 2024 Jun 9;13(2):93341. doi: 10.5409/wjcp.v13.i2.93341.
5
Fecal calgranulin as a potential screening tool to differentiate inflammatory bowel disease from irritable bowel syndrome.粪便钙卫蛋白作为区分炎症性肠病和肠易激综合征的潜在筛查工具。
Indian J Gastroenterol. 2024 Feb;43(1):264-266. doi: 10.1007/s12664-024-01525-1.
6
Effect of esomeprazole with and without a probiotic on fecal dysbiosis, intestinal inflammation, and fecal short-chain fatty acid concentrations in healthy dogs.埃索美拉唑联合或不联合益生菌对健康犬粪便菌群失调、肠道炎症和粪便短链脂肪酸浓度的影响。
J Vet Intern Med. 2023 Nov-Dec;37(6):2109-2118. doi: 10.1111/jvim.16886. Epub 2023 Sep 30.
7
Plasminogen Activator Inhibitor 1 Is a Novel Faecal Biomarker for Monitoring Disease Activity and Therapeutic Response in Inflammatory Bowel Diseases.纤溶酶原激活物抑制剂 1 是一种新型粪便生物标志物,可用于监测炎症性肠病的疾病活动和治疗反应。
J Crohns Colitis. 2024 Mar 1;18(3):392-405. doi: 10.1093/ecco-jcc/jjad160.
8
Case report: a premature infant with severe intrauterine growth restriction, adrenal insufficiency, and inflammatory diarrhea: a genetically confirmed case of MIRAGE syndrome.病例报告:一例严重宫内生长受限、肾上腺皮质功能不全和炎症性腹泻的早产儿:MIRAGE 综合征的基因确诊病例。
Front Endocrinol (Lausanne). 2023 Sep 6;14:1242387. doi: 10.3389/fendo.2023.1242387. eCollection 2023.
9
Is canine calprotectin in serum stabile after storage at low temperature?血清中犬 calprotectin 在低温储存后是否稳定?
BMC Vet Res. 2022 Dec 24;18(1):451. doi: 10.1186/s12917-022-03534-8.
10
Functional recovery outcomes following acute stroke is associated with abundance of gut microbiota related to inflammation, butyrate and secondary bile acid.急性中风后的功能恢复结果与大量与炎症、丁酸和次级胆汁酸相关的肠道微生物群有关。
Front Rehabil Sci. 2022 Oct 26;3:1017180. doi: 10.3389/fresc.2022.1017180. eCollection 2022.
基于家庭的粪便钙卫蛋白测量与 ELISA 结果在监测炎症性肠病活动中的一致性。
Clin Gastroenterol Hepatol. 2017 Nov;15(11):1742-1749.e2. doi: 10.1016/j.cgh.2017.06.007. Epub 2017 Jun 10.
4
Correlation Between Concentrations of Fecal Calprotectin and Outcomes of Patients With Ulcerative Colitis in a Phase 2 Trial.在一项 2 期临床试验中,粪便钙卫蛋白浓度与溃疡性结肠炎患者结局的相关性。
Gastroenterology. 2016 Jan;150(1):96-102. doi: 10.1053/j.gastro.2015.09.001. Epub 2015 Sep 12.
5
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.炎症性肠病治疗靶点选择(STRIDE):确定达标治疗的治疗目标
Am J Gastroenterol. 2015 Sep;110(9):1324-38. doi: 10.1038/ajg.2015.233. Epub 2015 Aug 25.
6
The intra-individual variability of faecal calprotectin: a prospective study in patients with active ulcerative colitis.粪便钙卫蛋白的个体内变异性:活动性溃疡性结肠炎患者的前瞻性研究。
J Crohns Colitis. 2015 Jan;9(1):26-32. doi: 10.1016/j.crohns.2014.06.002.
7
Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study.粪便中中性粒细胞主导蛋白钙卫蛋白的评估:一项方法学研究。
Scand J Gastroenterol. 1992 Sep;27(9):793-8. doi: 10.3109/00365529209011186.